Edward H. Kaplan MD & Associates

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Myelodysplastic syndromes2 trials
• Acute myeloid leukaemia1 trial
• Gastric and oesophageal cancer1 trial
• Myeloproliferative neoplasms1 trial

Phase

• Phase 21 trial
• Phase 2/31 trial

Status

• Active, not recruiting1 trial
• Completed1 trial
• Terminated1 trial

Lead sponsor

• Agios Pharmaceuticals, Inc.1 trial
• Celgene1 trial
• MacroGenics1 trial

Running trials

• Active, not recruiting

  A Study of Tebapivat (AG-946) in Participants With Anemia Due to Lower-Risk Myelodysplastic Syndromes (LR-MDS)

  NCT05490446· Phase 2· Agios Pharmaceuticals, Inc.· Source

Closed trials

• Completed

  Combination Margetuximab, Retifanlimab, Tebotelimab, and Chemotherapy Phase 2/3 Trial in HER2+ Gastric/GEJ Cancer

  NCT04082364· Phase 2/3· MacroGenics· Source

• Terminated

  Connect® Myeloid Disease Registry

  NCT01688011· Celgene· Source